Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01525
|
|||||
Drug Name |
Puromycin
|
|||||
Synonyms |
puromycin; Stylomycin; Puromycinum; Puromycine; Puromicina; UNII-4A6ZS6Q2CL; P-638; Stillomycin; CL 13900; 3123L; 4A6ZS6Q2CL; 3'-(L-alpha-Amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyladenosine; (S)-3'-((2-Amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyladenosine; GNF-PF-2016; Puromycinum [INN-Latin]; Puromycine [INN-French]; Puromicina [INN-Spanish]; 9-{3-deoxy-3-[(O-methyl-L-tyrosyl)amino]-beta-D-xylofuranosyl}-N,N-dimethyl-9H-purin-6-amine; Bacterenomycin
|
|||||
Indication | Bacterial infections [ICD11: 1A00-1H0Z] | Preclinical | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C22H29N7O5
|
|||||
Canonical SMILES |
CN(C)C1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)NC(=O)C(CC4=CC=C(C=C4)OC)N)O
|
|||||
InChI |
InChI=1S/C22H29N7O5/c1-28(2)19-17-20(25-10-24-19)29(11-26-17)22-18(31)16(15(9-30)34-22)27-21(32)14(23)8-12-4-6-13(33-3)7-5-12/h4-7,10-11,14-16,18,22,30-31H,8-9,23H2,1-3H3,(H,27,32)/t14-,15+,16+,18+,22+/m0/s1
|
|||||
InChIKey |
RXWNCPJZOCPEPQ-NVWDDTSBSA-N
|
|||||
CAS Number |
CAS 53-79-2
|
|||||
Pharmaceutical Properties | Molecular Weight | 471.5 | Topological Polar Surface Area | 161 | ||
Heavy Atom Count | 34 | Rotatable Bond Count | 8 | |||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 10 | |||
XLogP |
0
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:17939
|
|||||
DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [3] | ||
References | ||||||
1 | Inhibitors of ribosome functions. Annu Rev Microbiol. 1971;25:487-562. | |||||
2 | A prediction model of substrates and non-substrates of breast cancer resistance protein (BCRP) developed by GA-CG-SVM method. Comput Biol Med. 2011 Nov;41(11):1006-13. | |||||
3 | ATP-binding cassette transporters as pitfalls in selection of transgenic cells. Anal Biochem. 2010 Apr 15;399(2):246-50. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.